Patent classifications
C09B67/0025
USES OF CO-CRYSTALS
The present invention discloses new uses of coloured co-crystals and associated salts formed by co-crystallization reactions in the dye, ink and paint industries. The present invention also provides novel co-crystals for use in, for example, the dye, ink and/or paint industries.
CRYSTAL OF INDOCYANINE COMPOUND
The present invention is a crystal of 3-(3-{[3-(cyclomaltoheptaos-21-O-yl)propyl]amino}-3-oxopropyl)-2-{(1E)-2-[(3E)-3-{(2E)-2-[3-(3-{[3-(cyclomaltoheptaos-21-O-yl)propyl]amino}-3-oxopropyl)-1,1-dimethyl-1,3-dihydro-2H-benzo[e]indo1-2-ylidene]ethylidene}-2-methoxycyclohex-1-en-1-yl]ethen-1-yl}-1,1-dimethyl-1H-benzo [e]indol-3-ium chloride.
METHOD FOR PREPARING COLORANT HAVING TARGET COLOR AND COLORANT
The present disclosure relates to a method for preparing a colorant having a target color and the colorant. The method includes configuring submicron particles prepared from a predetermined material to have a predetermined size; adjusting a ratio of the submicron particles to cuttlefish juice submicron particles to a predetermined ratio; evaporating a predetermined solution mixed with the submicron particles and the cuttlefish juice submicron particles to obtain an amorphous photonic crystal structure; acquiring spectral data for reflected light generated by incident light irradiating the amorphous photonic crystal structure; determining whether the spectral data meets a predetermined condition, wherein the predetermined condition is associated with the target color; and responsive to determining that the spectral data does not meet the predetermined condition, adjusting at least one of the ratio or a size of each of the submicron particles until the spectral data meets the predetermined condition.
Squarylium dye and composition containing same
A squarylium dye [A] that has high invisibility, i.e., exhibits low absorption in the visible light region (400 nm to 750 nm), has excellent near-infrared absorption capability and high light resistance, tends not to exhibit aggregations, and has specific X-ray diffraction peaks; and an image-forming material and the like containing the squarylium dye [A] having said characteristics. The problem is solved by a squarylium dye [A] having specific X-ray diffraction peaks represented by general formula (1). Moreover, the problem is also solved by various materials containing the squarylium dye [A].
Process for the preparation of indigotindisulfonate sodium (indigo carmine)
This invention relates to an improved method for the preparation of highly or substantially pure Indigotindisulfonate sodium (1). It further relates to the novel crystalline form I of Indigotindisulfonate sodium (1) and the process for its preparation.
PROCESS FOR THE PREPARATION OF SODIUM 4-(2-((1E,3E,5E,7Z)-7-(1,1-DIMETHYL-3-(4-SULFONATOBUTYL)-1H-BENZO[e]INDOL-2(3H)-YLIDENE) HEPTA-1,3,5-TRIENYL)-1,1-DIMETHYL-1H-BENZO[e]INDOLIUM-3-YL) BUTANE-1-SULFONATE (INDOCYANINE GREEN)
A process for the preparation of substantially pure Indocyanine green of formula with purity greater than 99.0% is provided. More particularly, the embodiments relate to the process for the preparation of Indocyanine green of formula and its intermediates thereof. It further provides crystalline form I of Indocyanine green of formula and process thereof.
PROCESS FOR THE PREPARATION OF INDIGOTINDISULFONATE SODIUM (INDIGO CARMINE)
This invention relates to an improved method for the preparation of highly or substantially pure Indigotindisulfonate sodium (1). It further relates to the novel crystalline form I of Indigotindisulfonate sodium (1) and the process for its preparation.
NEW CRYSTAL FORM OF AN ORGANIC FLUORESCENT COMPOUND
The present invention relates to a new crystal form of the compound of formula and a process for its preparation. The compound may be used in compositions for inks, paints and plastics, especially in a wide variety of printing systems and is particularly well-suited for security applications.
##STR00001##
USE OF CHARGE-BALANCED IMAGING AGENTS FOR DETERMINING RENAL FUNCTION
The present invention relates to a method for detecting renal disease and for assessing the efficacy of dialysis treatment using imaging agents having desirable in vivo properties.
TRICYCLIC OCTACATIONIC CYCLOPHANE AND ITS USE IN COMPLEXATION WITH PERLENE DIIMIDE DYES
Disclosed herein is a tricyclic octacationic cyclophane and complexes comprising the tricyclic octacationic cyclophane and a perylene diimide dye complexed therein and methods of using and making the cyclophane and complexes.